PPP5D1P: A Drug Target / Disease Biomarker (G100506012)

Target Name: PPP5D1P

NCBI ID: G100506012

PPP5D1P

Other Name(s): PPP5D1P variant 1 | Protein PPP5D1 isoform 1 | PPP5D1 | PPP5 TPR repeat domain-containing protein 1 | PPP5 tetratricopeptide repeat domain containing 1, pseudogene, transcript variant 1 | PPP5 tetratricopeptide repeat domain containing 1, pseudogene

PPP5D1P: A Drug Target / Disease Biomarker

PPP5D1P is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of the polygenic programming pathway (PPP), a process that involves the regulation of gene expression by DNA methylation.

PPP5D1P has been identified as a potential drug target due to its involvement in a variety of physiological processes, including the regulation of cellular growth, apoptosis, and inflammation. It is also has been shown to be involved in the development and progression of a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of PPP5D1P is its role in the regulation of DNA methylation. DNA methylation is a process by which methyl groups are added to the promoter region of a gene, effectively turning it off. This regulation is important for the regulation of gene expression and is involved in the development and maintenance of various tissues and organs.

In addition to its role in DNA methylation, PPP5D1P is also involved in the regulation of cellular growth and apoptosis. Cellular growth is a critical process that is necessary for the development and maintenance of all tissues and organs, and it is regulated by a variety of factors, including PPP5D1P. When cells are growing, PPP5D1P helps to ensure that they are able to divide and grow in a controlled manner, and when they are no longer needed, it helps to induce them to undergo apoptosis, or programmed cell death.

PPP5D1P is also involved in the regulation of inflammation. Chronic inflammation is a major risk factor for a variety of diseases, including heart disease, cancer, and neurodegenerative disorders. PPP5D1P has been shown to play a role in the regulation of inflammatory responses and has been shown to be involved in the development of chronic inflammation.

In addition to its involvement in the regulation of DNA methylation, PPP5D1P is also involved in the regulation of cellular growth and apoptosis. Cellular growth is a critical process that is necessary for the development and maintenance of all tissues and organs, and it is regulated by a variety of factors, including PPP5D1P. When cells are growing, PPP5D1P helps to ensure that they are able to divide and grow in a controlled manner, and when they are no longer needed, it helps to induce them to undergo apoptosis, or programmed cell death.

PPP5D1P is also involved in the regulation of inflammation. Chronic inflammation is a major risk factor for a variety of diseases, including heart disease, cancer, and neurodegenerative disorders. PPP5D1P has been shown to play a role in the regulation of inflammatory responses and has been shown to be involved in the development of chronic inflammation.

Overall, PPP5D1P is a protein that is involved in a variety of physiological processes and has been identified as a potential drug target. Its role in the regulation of DNA methylation, cellular growth and apoptosis, and inflammation makes it a promising target for future research and treatment.

Protein Name: PPP5 Tetratricopeptide Repeat Domain Containing 1, Pseudogene

The "PPP5D1P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PPP5D1P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets